Posts Tagged ‘Moderna’
FDA approves new Pfizer, Moderna vaccines as COVID wave increases – Nick Landekic
by Nick Landekic, contributing The U.S. Food and Drug Administration on Thursday approved the latest reformulated COVID vaccines, making it possible for people over 6 months of age to get additional protection in the midst of the ongoing and still increasing surge this summer of the virus. What you need to know: We are now…
Read MoreNew updated COVID-19 Boosters now available in Rhode Island
Updated COVID-19 Booster Doses to be Available in Rhode Island Bivalent boosters to target two strains of COVID-19 With a new, more comprehensive COVID-19 booster dose now authorized and recommended by federal health officials, these updated booster shots will start to become available in Rhode Island this week and next. “This is a good reminder…
Read MoreModerna and Pfizer COVID vaccine for children 6 months+ gets FDA approval
Today, the U.S. Food and Drug Administration authorized emergency use of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 to include use in children down to 6 months of age. CVS has announced it will provide vaccines for children 18 months and older – otherwise parents can access their…
Read MoreNEW: Moderna announces new booster that is Omicron variant specific
Moderna announces new booster that is Omicron variant specific Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced new clinical data on its Omicron-containing bivalent COVID booster candidate, mRNA-1273.214, containing mRNA-1273 (Spikevax) and a vaccine candidate targeting the Omicron variant of concern. A 50 µg booster dose of mRNA-1273.214 met…
Read MoreMoving ahead with COVID vaccines for young children
Moderna (6 mos-5 yrs) and Pfizer (5-11 yrs booster) are next up seeking approval as vaccines. The Moderna will be 2 shots, 4 weeks apart, at 25% strength of an adult shot for children 6 mos to 5 years. Pfizer’s approval request is for a booster for children 5 to 11. After the age of…
Read MoreModerna COVID vaccine should be coming soon for children 6 months to 6 years
Moderna, Inc. announced Wednesday that positive interim data from the Phase 2/3 KidCOVE study of the Moderna COVID-19 vaccine in children 6 months to under 2 years and 2 years to under 6 years of age. This interim analysis showed a robust neutralizing antibody response in both age groups after a 25 µg two-dose primary…
Read MoreModerna joins Pfizer in recommending 4th vaccine, but expands to all adults, 18+
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has submitted a request to the U.S. Food and Drug Administration (FDA) for an amendment to the emergency use authorization (EUA) to allow for a fourth dose of its COVID-19 vaccine (mRNA-1273) in adults 18 years of age and…
Read MoreModerna, Johnson & Johnson Boosters available now – Mix & Match OK
Moderna, Johnson & Johnson COVID-19 Vaccine Boosters Now Available; Recommendations Allow Individuals to Choose Type of Vaccine for Booster Dose Governor Dan McKee and the Rhode Island Department of Health announced today that Moderna and Johnson & Johnson (Janssen) COVID-19 vaccine boosters are now available and recommended as follows: Moderna A single booster dose of…
Read MoreNEW: CDC recommends immunocompromised get additional vaccine 28 days after 2nd vaccine
COVID-19 Vaccines for Moderately to Severely Immunocompromised People What You Need to Know People with moderately to severely compromised immune systems are especially vulnerable to COVID-19, and may not build the same level of immunity to 2-dose vaccine series compared to people who are not immunocompromised. CDC recommends that people with moderately to severely compromised…
Read MoreVaccinating children, as young as 6 months, may be focus by the fall
Moderna’s CEO said at a professional conference yesterday that he predicted that its COVID-19 vaccine will likely be available for children as young as five by the early fall. “I think it’s going to be early fall, just because we have to go down in age very slowly and carefully,” the Cambridge-based company’s CEO Stéphane…
Read More